TG Therapeutics, Inc.
$49.76
USD
Last updated on --.
24h volume1.23M
24h highest50.1840 USD
24h lowest49.1160 USD
24h Price movement+0.00%
TGTX recent prices
24 Hours
+0.00%$0.00
30 days
-15.75%-$9.300
60 days
+14.73%+$6.390
90 days
+15.35%+$6.620
Key data
Previous close49.7600 USD
Market cap7.58B USD
Volume1.23M
P/E ratio17.180000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)2.8800 USD
Net income (FY)441.49M USD
Revenue (FY)799.54M USD
Last report dateAug 5, 2026
About TG Therapeutics, Inc.
HeadquartersNEW YORK
Employees (FY)399.00
Revenue per employee (FY)2.00M USD
Net income per employee (FY)1.11M USD
Listed onNasdaq
TGTX conversion tables
 |  |
|---|---|
| 0.5 TGTX | 24.88 USD |
| 1 TGTX | 49.76 USD |
| 5 TGTX | 248.8 USD |
| 10 TGTX | 497.6 USD |
| |
|---|---|
| 0.5 USD | 0.010048 TGTX |
| 1 USD | 0.020096 TGTX |
| 5 USD | 0.10048 TGTX |
| 10 USD | 0.20096 TGTX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
TGTX is trading at $49.76, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TGTX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TGTX is currently trading at $49.76, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TGTX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TGTX's P/E ratio is currently 17.180000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TGTX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TGTX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
TG Therapeutics, Inc.'s market cap is currently 7.58B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.23M
24h highest50.1840 USD
24h lowest49.1160 USD
24h Price movement+0.00%
Start trade with TGTX Perpetual
Sign up to trade